News

New Hearing Loss Warnings Added to Tepezza Drug Label

Continue Reading

Elevated Risk of Ovarian Cancer Seen Among Hairdressers, Other Beauty Salon Workers

Continue Reading

PFAS Chemicals Found in Nearly Half of Nation’s Tap Water Supply: Report

Continue Reading

L’Oreal, Other Hair Relaxer Manufacturers Withheld Cancer Risk from Users for Decades, Lawsuit Alleges

Continue Reading

Proposed Bill Would Require Military Bases to Report PFAS Water Contamination

Continue Reading

Hearing Acuity Testing Should Have Been Recommended for Tepezza Users, Lawsuit Alleges

Continue Reading

3M Will Pay Up to $12.5 Billion to Resolve PFAS Water Contamination Claims

Continue Reading

Prenatal Exposure to PFAS Linked to Childhood Obesity in New Study

Continue Reading

3M May Be in Talks to Settle Firefighter Foam Lawsuits Over Exposure to “Forever Chemicals”

Continue Reading

Families Pursuing Tylenol Lawsuits Following Autism/ADHD Diagnoses

Continue Reading

Jury Returns Defense Verdict in Missouri Roundup Cancer Trial

Continue Reading

3M CEO Will Attend Combat Arms Earplug Settlement Negotiations: Court Order

Continue Reading

Elmiron Vision Impairment Lawsuit Update: May 2023

Continue Reading

Johnson & Johnson Seeks Dismissal of Tylenol Autism and ADHD Lawsuits

Continue Reading

Tepezza Treatment Carries Hidden Hearing Loss Risk: Lawsuit

Continue Reading

L’Oreal, Other Beauty Brands Urged to Remove Hair Relaxers from Market in Light of Cancer Risk

Continue Reading

Do I Qualify for an Elmiron Injury Lawsuit?

Continue Reading

Lawsuit Claims Tepezza User Could Have Avoided Hearing Problems with Better Warnings

Continue Reading

Plaintiffs in Tylenol MDL Propose Acetaminophen Pregnancy Warnings for Autism, ADHD

Continue Reading

Proposed Settlement Fund Would Pay $9 Billion to Talcum Powder Cancer Victims

Continue Reading